Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
CA 2257422 A1 · Owner: F. Hoffmann-La Roche Ag · Inventors: Shirai, Haruyoshi; Yabuki, Nami; Takehana, Yuki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (I), wherein R1 and R2 are independently hydrogen unsubstituted lower alkyl or lower alkyl substituted by lower alkoxy or lower alkyl thio, or acyl which is unsubstituted or substituted by one or more of lower alkyl, lower alkyl substituted by halogen and lower alkoxy; X is CO or , CHOH; Y is CO or CH2; and Z is O or NH and epimers and enantiomers thereof, or the physiologically usable salts thereof are useful as anti-tumor agents. They can be prepared by fermentation of Aspergillus sp. and optionally, subsequent modification of functional groups.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 30, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 30, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 30, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.